drugset / Trial / NCT03045926

Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic Diarrhoea

NCT03045926

Phase 1 Completed 35 enrolled Ipsen
NaSingle-groupOpen-labelOther

Summary

The main purpose of this study is to assess the concentration of elemental impurities in blood and urine after chronic administration of Smecta® in subjects with chronic functional diarrhoea. For exploratory purposes, the potential effects of diosmectite on bowel microbiote composition will be investigated.

Timeline

Start
2016-08
Primary completion
2017-05-09
Completion
2017-05-09

Drugs

EvaluationDrugModalityDoseRoute
Subject montmorillonite Other / unclassified 3 g

Indications